-

MedImpact Receives Three-Year NCQA Reaccreditation

Reaffirms commitment to high quality standards and rigorous process assessment in Utilization Management

SAN DIEGO--(BUSINESS WIRE)--MedImpact, the independent pharmacy benefit manager (PBM) and health solutions company that puts clients and consumers first, announced today that it has been awarded a three-year reaccreditation in Utilization Management by the National Committee for Quality Assurance (NCQA). NCQA’s mission is to improve the quality of health care.

MedImpact was awarded the three-year accreditation by NCQA in Utilization Management following a rigorous assessment of its systems, processes, and personnel in utilization management to ensure NCQA’s high standards are met. This achievement marks MedImpact’s third consecutive successful NCQA accreditation in Utilization Management.

“For over 30 years, MedImpact has helped ensure members receive the services and prescriptions they need for better health, while reducing the risks and costs associated with over-utilizing resources. NCQA accreditation is the gold standard for quality in healthcare, and we are pleased to be recognized for our clinical excellence, unrelenting commitment to members, and track record of continuous improvement.”

- Denise Burns, Chief Operations Officer, MedImpact

As an independent nonprofit, NCQA works to improve the quality of healthcare and conducts voluntary, objective, and evidence-based evaluations. NCQA accreditation is critical for PBM partnerships with health plans, managed care organizations, and accountable care organizations.

“Achieving NCQA Utilization Management Accreditation demonstrates that MedImpact has the systems, process and personnel in place to conduct utilization management in accordance with the strictest quality standards,” stated Margaret E. O’Kane, President, NCQA.

Since its inception, MedImpact has invested heavily in building a world-class clinical team, leading the way in innovation, and providing high touch member services. This approach delivers forward-thinking utilization management, high-touch member engagement programs, and low year-over-year cost trend. Today, MedImpact is the largest independent PBM, serving many of the nation’s most recognizable health plans and self-insured employers, and more than 55 million consumers globally.

“This commitment to quality and continuous quality improvement highlights MedImpact’s dedication to providing excellence in PBM services that support our clients’ success in delivering high value to their members. Along with our URAC PBM Accreditation, this NCQA Utilization Management Accreditation reaffirms our commitment to quality and distinguishes MedImpact with accreditations from two national industry leaders in health care,” said Burns. “For our clients, it means providing service excellence by helping to ensure that prescription benefits are consistently and accurately administered. For members, it means helping to ensure that they receive timely approval of clinically appropriate and necessary medications.”

NCQA has reviewed and accredited MedImpact’s Utilization Management functions only. For complete details on the scope of this review, visit www.ncqa.org.

About MedImpact

MedImpact is the PBM and health solutions company that puts clients and consumers first. For over 30 years, it has had a single mission: To make pharmacy benefits affordable, understandable, and transparent. Today, MedImpact’s team and technology serve many large employers and plans, and more than 55 million consumers in the US and around the world. Learn more at medimpact.com or follow us on Twitter @MedImpact.

About NCQA

NCQA is a private, non-profit organization dedicated to improving health care quality. NCQA accredits and certifies a wide range of healthcare organizations. It also recognizes clinicians and practices in key areas of performance. NCQA’s Healthcare Effectiveness Data and Information Set (HEDIS®) is the most widely used performance measurement tool in health care. NCQA’s website (ncqa.org) contains information to help consumers, employers and others make more informed health care choices. NCQA can be found online at ncqa.org, on Twitter @ncqa, on Facebook at facebook.com/NCQA.org/ and on LinkedIn at linkedin.com/company/ncqa.

Contacts

MedImpact


Release Versions

Contacts

More News From MedImpact

MedImpact Redefines Obesity Care with New Suite of GLP-1 Solutions

SAN DIEGO--(BUSINESS WIRE)--MedImpact, the nation’s largest independent pharmacy benefits and health solutions company, today announced the launch of two pioneering solutions designed to help plan sponsors manage the skyrocketing cost of GLP-1 medications, while improving member access and care: GLP-1 Benefit 360 and GLP-1 Direct Fund. At a time when demand for weight-loss medication is at an all-time high, the launch of these products marks another milestone in MedImpact’s strategy to utilize...

MedImpact Expands Portfolio of Health Solutions with Acquisition of Two Employer Insurance and Risk Management Companies

SAN DIEGO--(BUSINESS WIRE)--MedImpact Holdings, Inc., the nation’s largest independent health solutions and pharmacy benefit company, today announced the acquisition of two innovative risk management firms: MHW Benefit Partners (formerly SRS Benefit Partners) and MSL Captive Solutions. These acquisitions expand MedImpact’s portfolio of care and coverage solutions, providing employers with modular, cost-effective alternatives to traditional insurance carriers. By integrating specialized risk man...

MedImpact Offers Humira Biosimilar 95% Below the Cost of Humira to Any Hospital or Pharmacy

SAN DIEGO--(BUSINESS WIRE)--MedImpact Holdings, Inc. today announced the launch of an unbranded biosimilar to Humira® (adalimumab) priced at 95% below the brand-name cost. MedImpact is offering this biosimilar (adalimumab-ryvk), manufactured by Anda, an affiliate of Teva Pharmaceuticals USA, Inc., through its preferred partner, Birdi Inc., to any hospital, plan, or pharmacy nationwide—not just its own clients or affiliates. “For too long, the industry has used supply chain complexity to inflate...
Back to Newsroom